Anticoagulation

Printing and PDF export are disabled for this protected preview. Continue reading inside the DiraChart reader.

Trace DC32-4

DiraChart Clinical Reference
Protected section 4 of 14
← Document menu
Home Care · DiraChart

1. Where this overlay applies

DiraChart Clinical Reference

Section NavigationPart 4 of 14PreviousNext

3. Key visit elements

Add these anticoagulation-specific elements at each visit alongside the parent examinations — this is not a repeat of the full exam:

  • Bleeding surveillance: skin (bruising, petechiae), gums, epistaxis, hematuria, melena or hematochezia, and hemoptysis; a fall and head-injury screen.
  • Thromboembolic surveillance per indication: deep-vein thrombosis signs (Peripheral Vascular), stroke or embolism symptoms (Neurological), and atrial-fibrillation rate and rhythm (Cardiovascular).
  • INR result reviewed and trended against the ordered range (warfarin); renal function reviewed against the ordered schedule (DOAC).
  • Medication adherence; a new-medication and OTC or supplement interaction screen (NSAIDs, certain antibiotics and antifungals, amiodarone, and vitamin-K-containing foods for warfarin).
  • Dietary vitamin-K consistency (warfarin) and an alcohol screen.
Section NavigationPart 4 of 14PreviousNext